EdgarLookup

loanDepot, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that loanDepot, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-0.9%
Return on Assets
Net income ÷ assets

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($62.65M) Mar 12, 2026
FY2025 Dec 31, 2024 ($98.33M) Mar 12, 2026
FY2025 Dec 31, 2023 ($110.14M) Mar 12, 2026
FY2024 Dec 31, 2022 ($273.02M) Mar 13, 2025
FY2023 Dec 31, 2021 $113.52M Mar 15, 2024
FY2022 Dec 31, 2020 $0 Mar 16, 2023
FY2021 Dec 31, 2019 $0 Mar 18, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($707.51M) Mar 12, 2026
FY2025 Dec 31, 2024 ($858.31M) Mar 12, 2026
FY2025 Dec 31, 2023 ($174.22M) Mar 12, 2026
FY2024 Dec 31, 2022 $4.46B Mar 13, 2025
FY2023 Dec 31, 2021 ($1.47B) Mar 15, 2024
FY2022 Dec 31, 2020 ($2.03B) Mar 16, 2023
FY2021 Dec 31, 2019 ($1.50B) Mar 18, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $27.10M Mar 12, 2026
FY2025 Dec 31, 2024 $26.39M Mar 12, 2026
FY2025 Dec 31, 2023 $20.61M Mar 12, 2026
FY2024 Dec 31, 2022 $43.21M Mar 13, 2025
FY2023 Dec 31, 2021 $54.12M Mar 15, 2024
FY2022 Dec 31, 2020 $33.91M Mar 16, 2023
FY2021 Dec 31, 2019 $12.55M Mar 18, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.86B Mar 12, 2026
FY2025 Dec 31, 2024 $6.34B Mar 12, 2026
FY2024 Dec 31, 2023 $6.15B Mar 13, 2025
FY2023 Dec 31, 2022 $6.61B Mar 15, 2024
FY2022 Dec 31, 2021 $11.81B Mar 16, 2023
FY2021 Dec 31, 2020 $10.89B Mar 18, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.47B Mar 12, 2026
FY2025 Dec 31, 2024 $5.84B Mar 12, 2026
FY2024 Dec 31, 2023 $5.45B Mar 13, 2025
FY2023 Dec 31, 2022 $5.69B Mar 15, 2024
FY2022 Dec 31, 2021 $10.18B Mar 16, 2023
FY2021 Dec 31, 2020 $9.24B Mar 18, 2022

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $0 Mar 16, 2023
FY2022 Dec 31, 2021 $40.74M Mar 16, 2023
FY2022 Dec 31, 2020 $40.74M Mar 16, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($614.40M) Mar 12, 2026
FY2025 Dec 31, 2024 ($550.62M) Mar 12, 2026
FY2024 Dec 31, 2023 ($451.71M) Mar 13, 2025
FY2023 Dec 31, 2022 ($342.14M) Mar 15, 2024
FY2022 Dec 31, 2021 ($28.98M) Mar 16, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $337.23M Mar 12, 2026
FY2025 Dec 31, 2024 $421.58M Mar 12, 2026
FY2025 Dec 31, 2023 $660.71M Mar 12, 2026
FY2024 Dec 31, 2022 $863.96M Mar 13, 2025
FY2022 Dec 31, 2021 $419.57M Mar 16, 2023
FY2021 Dec 31, 2020 $284.22M Mar 18, 2022

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.10B Mar 12, 2026
FY2025 Dec 31, 2024 $2.03B Mar 12, 2026
FY2024 Dec 31, 2023 $2.27B Mar 13, 2025
FY2023 Dec 31, 2022 $2.29B Mar 15, 2024
FY2022 Dec 31, 2021 $1.63B Mar 16, 2023
FY2021 Dec 31, 2020 $712.47M Mar 18, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 (1) Mar 16, 2023
FY2022 Dec 31, 2021 0 Mar 16, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 (1) Mar 16, 2023
FY2022 Dec 31, 2021 0 Mar 16, 2023